JWA
GH icon

JFS Wealth Advisors’s Guardant Health GH Stock Holding History

JFS Wealth Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.25K Sell
55
-3
-5% -$326 ﹤0.01% 1092
2026
Q1 		$5.36K Buy
58
+2
+4% +$201 ﹤0.01% 1174
2025
Q4 		$5.72K Buy
56
+25
+81% +$2.24K ﹤0.01% 1182
2025
Q3 		$1.94K Hold
31
– – ﹤0.01% 1447
2025
Q2 		$1.61K Buy
31
+14
+82% +$625 ﹤0.01% 1448
2025
Q1 		$725 Buy
+17
New +$733 ﹤0.01% 1708
2024
Q1 		– Sell
-22
Closed -$596 – 2014
2023
Q4 		$596 Buy
22
+19
+633% +$498 ﹤0.01% 1771
2023
Q3 		$89 Buy
+3
New +$105 ﹤0.01% 1911
2022
Q2 		– Sell
-16
Closed -$1K – 1809
2022
Q1 		$1K Buy
16
+8
+100% +$547 ﹤0.01% 1645
2021
Q4 		$1K Buy
+8
New +$827 ﹤0.01% 1369
2021
Q1 		– Sell
-28
Closed -$4K – 604
2020
Q4 		$4K Buy
+28
New +$3.22K ﹤0.01% 492

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

JFS Wealth Advisors's GH Position: Q2 2026 in Review

JFS Wealth Advisors reduced its Guardant Health (GH) stake by 5.2% in Q2 2026, selling an estimated $326 and leaving 55 shares worth $8.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

JFS Wealth Advisors first reported a position in GH in Q4 2020 and has held it in 11 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • JFS Wealth Advisors held 55 shares of Guardant Health worth $8.25K as of Q2 2026.
  • JFS Wealth Advisors sold 3 Guardant Health shares in Q2 2026, an estimated $326.
  • Guardant Health made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #1092 holding.
  • JFS Wealth Advisors first reported a position in Guardant Health in Q4 2020 and has held it in 11 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.